M-End DMX and Tofacitinib Extended-Release Tablets
Determining the interaction of M-End DMX and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / dextromethorphan / pseudoephedrine
Brand name: M-End DMX
Synonyms: n.a.
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- M-End DMX-Tofacitinib Tablets
- M-End DMX-Tofranil
- M-End DMX-Tofranil injection
- M-End DMX-Tofranil-PM
- M-End DMX-Tol-Tab
- M-End DMX-Tolazamide
- Tofacitinib Extended-Release Tablets-M-End Max D
- Tofacitinib Extended-Release Tablets-M-End PE
- Tofacitinib Extended-Release Tablets-M-End WC
- Tofacitinib Extended-Release Tablets-M-Hist DM
- Tofacitinib Extended-Release Tablets-M-Hist PD
- Tofacitinib Extended-Release Tablets-M-M-R II